Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jubilant Biosys Limited, part of the Jubilant Pharmova group, provides integrated drug discovery, contract research, development, and manufacturing services globally. With over two decades of experience and more than a thousand scientists across India and international offices, it specializes in small molecules, biologics including antibody-drug conjugates, process R&D for APIs/intermediates/KSMs under GMP/non-GMP conditions. The company has delivered over eighty-five integrated drug discovery programs across oncology, metabolic disorders, pain/inflammation and CNS. It operates on flexible business models—FFS/FTE/risk-sharing—and supports partners from target identification through candidate selection to IND-enabling studies and early-phase GMP supply. It does not develop its own pipeline drugs but enables pharma/biotech companies’ pipelines at all preclinical/early clinical stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jubilant Biosys.